+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
From
Heart Failure Drugs Market 2021-2025 - Product Thumbnail Image

Heart Failure Drugs Market 2021-2025

  • Report
  • January 2022
  • 120 Pages
  • Global
From
Anaplastic Astrocytoma Global Market Report 2024 - Product Thumbnail Image

Anaplastic Astrocytoma Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Intratumoral Cancer Therapies Global Market Report 2024 - Product Thumbnail Image

Intratumoral Cancer Therapies Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Solid Tumor Cancer Treatment Global Market Report 2024 - Product Thumbnail Image

Solid Tumor Cancer Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Cancer Immunotherapy Global Market Report 2024 - Product Thumbnail Image

Cancer Immunotherapy Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors Market 2022-2026 - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors Market 2022-2026

  • Report
  • August 2022
  • 120 Pages
  • Global
From
From
From
Blood Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Blood Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
CAR-T - Pipeline Insight, 2024 - Product Thumbnail Image

CAR-T - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 450 Pages
  • Global
From
From
Loading Indicator